
### [NCIT:C7072](http://purl.obolibrary.org/obo/NCIT_C7072)
**Label:** Oncocytic Neoplasm

**Subclasses:** [NCIT:C45935](http://purl.obolibrary.org/obo/NCIT_C45935) (Pituitary Gland Oncocytic Adenoma), [NCIT:C5932](http://purl.obolibrary.org/obo/NCIT_C5932) (Salivary Gland Oncocytoma), [NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma), [NCIT:C4526](http://purl.obolibrary.org/obo/NCIT_C4526) (Kidney Oncocytoma), [NCIT:C95514](http://purl.obolibrary.org/obo/NCIT_C95514) (Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type), [NCIT:C82890](http://purl.obolibrary.org/obo/NCIT_C82890) (Cystic Oncocytic Neoplasm), [NCIT:C3679](http://purl.obolibrary.org/obo/NCIT_C3679) (Oxyphilic Adenocarcinoma), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C27393](http://purl.obolibrary.org/obo/NCIT_C27393) (Parathyroid Gland Oncocytic Adenoma), [NCIT:C8960](http://purl.obolibrary.org/obo/NCIT_C8960) (Hereditary Kidney Oncocytoma), [NCIT:C62194](http://purl.obolibrary.org/obo/NCIT_C62194) (Salivary Gland Oncocytic Carcinoma), [NCIT:C3759](http://purl.obolibrary.org/obo/NCIT_C3759) (Oncocytic Adenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C62273](http://purl.obolibrary.org/obo/NCIT_C62273) (Mixed Neoplastic Glandular and Squamous Cell Population) 55.56%
- Thing 52.40%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 40.91%
- [NCIT:C61544](http://purl.obolibrary.org/obo/NCIT_C61544) (Mixed Epithelial Cell Population) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 40.91%


